SEC Form 4 · accession 0001493152-17-003312

VBI Vaccines Inc/BC · VBIV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer

Period of report

Mar 29, 2017

Accepted (ET)

Mar 31, 2017 · 8:16 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000764195

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares, no par value per share	Mar 29, 2017	A	12,500	$0.00	A	251,839	D
Common Shares, no par value per share^F1	holding	—	—		—	19,404	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (Right to Buy Common Shares)^F2,F3,F4	$3.45	Mar 29, 2017	A	20,000	A	—	Jan 26, 2027	Common Shares	20,000	20,000	D

F1The common shares are held of record by 1120962 Ontario Inc. As the President of such corporation that owns 100% of its voting securities, the reporting person has the power to vote and dispose of the common shares held by the corporation.
F2Exercise price is in Canadian dollars, United States dollars equivalent is shown using the closing foreign exchange rate on the Grant Date (as defined below).
F3The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated March 29, 2017 (the "Option Agreement"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date.
F4The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.